R. Demeester

发表

Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants

P. Lacor, C. Verhofstede, D. Van Beckhoven, 2015, BMC Infectious Diseases.

A public health value-based healthcare paradigm for HIV

S. Vermeersch, L. Annemans, P. Messiaen, 2021, BMC Health Services Research.

Impact of collaborative physician-pharmacist stewardship strategies on prophylactic antibiotic practices: a quasi-experimental study

P. Duez, Antonelle Pardo, S. Cherifi, 2022, Antimicrobial resistance and infection control.

Adherence to first-line antiretroviral regimens in Rwanda.

V. Arendt, S. Schneider, R. Demeester, 2005, Journal of acquired immune deficiency syndromes.

Mutationen im Osophagus verursacht durch gastro-osophagealen Reflux Reflux induced esophageal mutations

J. Siewert, T. Demeester, K. Skinner, 2001 .

A rare variant, I852M, of the RET proto‐oncogene in a patient with medullary thyroid carcinoma at age 20 years

J. Parma, M. Abramowicz, G. Vassart, 2001, Human mutation.

High uptake of pre-exposure prophylaxis (PrEP) during early roll-out in Belgium: results from surveillance reports.

B. Vuylsteke, M. Laga, C. Nöstlinger, 2019, Sexual health.

Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care

K. Van Laethem, P. Messiaen, M. Moutschen, 2022, BMC Infectious Diseases.

Factors associated with the continuum of care of HIV-infected patients in Belgium

M. Van Ranst, M. Moutschen, P. Lacor, 2014, Journal of the International AIDS Society.

Hantavirus nephropathy as a pseudo-import pathology from Ecuador

P. Maes, E. Bottieau, M. van Esbroeck, 2009, European Journal of Clinical Microbiology & Infectious Diseases.

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

B. Gazzard, K. Tashima, M. Shields, 2019, The Lancet.

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

E. Goetghebeur, M. Montourcy, H. Van Oyen, 2020, International Journal of Antimicrobial Agents.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017

J. Yombi, S. De Wit, I. Derdelinckx, 2018, Acta clinica Belgica.

A traveler with neurobrucellosis.

H. Jansens, E. Vlieghe, E. van den Enden, 2009, Travel medicine and infectious disease.

Diversity of life-threatening complications due to Mediterranean spotted fever in returning travelers.

E. Bottieau, E. Vlieghe, M. Claus, 2010, Journal of travel medicine.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Acute increase in goiter size during a normal pregnancy: an exceptional case report.

D. Larsimont, D. Glinoer, G. Andry, 2003, Thyroid : official journal of the American Thyroid Association.

High number of hospitalisations and non-classical presentations: lessons learned from a measles outbreak in 2017, Belgium

V. Hutse, T. Asikainen, C. Wyndham-Thomas, 2020, Epidemiology and Infection.

Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real‐world setting in Belgium

P. Messiaen, J. Yombi, L. Vandekerckhove, 2023, HIV medicine.

Prevalence and European AIDS Clinical Society (EACS) criteria evaluation for proximal renal tubular dysfunction diagnosis in patients under antiretroviral therapy in routine setting

J. Legrand, R. Demeester, Lorenzo Pitisci, 2014, Journal of the International AIDS Society.

Prospective multicenter evaluation of the expert system "KABISA TRAVEL" in diagnosing febrile illnesses occurring after a stay in the tropics.

A. Pini, E. Bottieau, Z. Bisoffi, 2011, Journal of travel medicine.

Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium

P. Messiaen, J. Yombi, S. De Wit, 2022, HIV medicine.

CSF HIV RNA Escape in Opsoclonus-Myoclonus-Ataxia Syndrome: Case Report and Review of the Literature

J. Honnorat, M. Manto, P. Cabaraux, 2020, Frontiers in Neurology.

Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients

M. Moutschen, L. Vandekerckhove, S. De Wit, 2018, Acta clinica Belgica.

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients*

M. Moutschen, P. Lacor, S. De Wit, 2019, Acta clinica Belgica.